Effect of bevacizumab against cystic components of brain tumors

BACKGROUND: Bevacizumab improves symptoms via reducing the peritumoral edema and/or normalizing blood brain barrier, and occasionally via reducing the tumor size. However, the effect against active cystic components has not been documented yet. MATERIALS AND METHODS: Between 2008 and 2018, 139 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamasaki, Fumiyuki, Kolakshyapati, Manish, Takano, Motoki, Yonezawa, Ushio, Nishibuchi, Ikuno, Imano, Nobuki, Taguchi, Akira, Onishi, Shumpei, Amatya, Vishwa Jeet, Takeshima, Yukio, Nagata, Yasushi, Kurisu, Kaoru, Sugiyama, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825995/
https://www.ncbi.nlm.nih.gov/pubmed/31498567
http://dx.doi.org/10.1002/cam4.2537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825995/
https://www.ncbi.nlm.nih.gov/pubmed/31498567
http://dx.doi.org/10.1002/cam4.2537

Ejemplares similares